Patents by Inventor Said El Meski

Said El Meski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid dosage form for the ocular administration of an active principle, a soluble, solid ophthalmic insert and the production method thereof
    Patent number: 8663678
    Abstract: A solid dosage form for the ocular administration of an active principle includes at least one biocompatible, water-soluble excipient for ophthalmic use. The form is obtained using a method which is selected from among the following: direct compression, dry compression, wet compression, compression of a lyophilizate, the compression being carried out a temperature below 45° C., or lyophilization, such that the form can disintegrate and release the active principle in the conjunctival sac. The invention also relates to an ophthalmic insert having the aforementioned dosage form which is appropriately dimensioned for ocular administration.
    Type: Grant
    Filed: December 17, 2002
    Date of Patent: March 4, 2014
    Assignee: Laboratoires Thea
    Inventors: Saïd El Meski, Philippe Tourrette, Jean-Marc Aiache, Marie Di Battista, Gilbert Serpin
  • Intraocular lens containing releasable medication
    Patent number: 7939097
    Abstract: An intraocular implant adapted to come in contact with the aqueous humor comprises a hydrophilic polymer having a predetermined water content for implantation in an eye, an effective quantity of a medicated product for treatment of the eye being dispersed in the mass of the hydrophilic polymer of the implant, the association of the hydrophilic polymer and the dispersed medicated product being adapted to release the product progressively into the aqueous humor.
    Type: Grant
    Filed: March 25, 2003
    Date of Patent: May 10, 2011
    Assignee: Carl Zeiss Meditec SAS
    Inventors: Jean-Marc Aiache, Gilbert Serpin, Said El Meski, Philippe Tourrette
  • Solid dosage form for the ocular administration of an active principle, a soluble, solid ophthalmic insert and the production method thereof
    Publication number: 20050118231
    Abstract: A solid dosage form for the ocular administration of an active principle includes at least one biocompatible, water-soluble excipient for ophthalmic use. The form is obtained using a method which is selected from among the following: direct compression, dry compression, wet compression, compression of a lyophilizate, the compression being carried out a temperature below 45° C., or lyophilization, such that the form can disintegrate and release the active principle in the conjunctival sac. The invention also relates to an ophthalmic insert having the aforementioned dosage form which is appropriately dimensioned for ocular administration.
    Type: Application
    Filed: December 17, 2002
    Publication date: June 2, 2005
    Inventors: Said El Meski, Philippe Tourrette, Jean-Marc Aiache, Marie Di Battista, Gilbert Serpin
  • Intraocular lens containing releasable medication
    Patent number: 6713080
    Abstract: The present invention relates to an intra-ocular lens that is made from hydrophilic polymer. An effective amount of medicine is dispersed in the mass of the of the polymer and when implanted in the eye of a subject, the lens releases the medicine into the intra-ocular tissues so that the medicine is in the vicinity of the site where action is needed.
    Type: Grant
    Filed: June 14, 1999
    Date of Patent: March 30, 2004
    Assignee: Ioltechnologie-Production
    Inventors: Jean-Marc Aiache, Gilbert Serpin, Said El Meski, Philippe Tourrette
  • Intraocular lens containing releasable medication
    Publication number: 20030232066
    Abstract: An intraocular implant adapted to come in contact with the aqueous humor comprises a hydrophilic polymer having a predetermined water content for implantation in an eye, an effective quantity of a medicated product for treatment of the eye being dispersed in the mass of the hydrophilic polymer of the implant, the association of the hydrophilic polymer and the dispersed medicated product being adapted to release the product progressively into the aqueous humor.
    Type: Application
    Filed: March 25, 2003
    Publication date: December 18, 2003
    Applicant: IOLTECHNOLOGIE-PRODUCTION
    Inventors: Jean-Marc Aiache, Gilbert Serpin, Said El Meski, Philippe Tourrette